UBS Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.81M | Buy |
33,510
+3,074
| +10% | +$349K | ﹤0.01% | 3284 |
|
|
2025
Q1 | $3.2M | Buy |
30,436
+3,331
| +12% | +$350K | ﹤0.01% | 3340 |
|
|
2024
Q4 | $2.9M | Buy |
27,105
+15,608
| +136% | +$1.67M | ﹤0.01% | 3411 |
|
|
2024
Q3 | $1.15M | Sell |
11,497
-27,289
| -70% | -$2.73M | ﹤0.01% | 3490 |
|
|
2024
Q2 | $3.27M | Buy |
38,786
+5,723
| +17% | +$482K | ﹤0.01% | 2440 |
|
|
2024
Q1 | $2.42M | Buy |
33,063
+14,036
| +74% | +$1.03M | ﹤0.01% | 2821 |
|
|
2023
Q4 | $1.36M | Buy |
19,027
+12,111
| +175% | +$865K | ﹤0.01% | 3193 |
|
|
2023
Q3 | $414K | Sell |
6,916
-1,159
| -14% | -$69.4K | ﹤0.01% | 3737 |
|
|
2023
Q2 | $582K | Buy |
8,075
+6,894
| +584% | +$497K | ﹤0.01% | 3705 |
|
|
2023
Q1 | $86.9K | Sell |
1,181
-479
| -29% | -$35.2K | ﹤0.01% | 4953 |
|
|
2022
Q4 | $111K | Buy |
1,660
+1,083
| +188% | +$72.3K | ﹤0.01% | 4889 |
|
|
2022
Q3 | $31K | Sell |
577
-497
| -46% | -$26.7K | ﹤0.01% | 5750 |
|
|
2022
Q2 | $60K | Sell |
1,074
-49,074
| -98% | -$2.74M | ﹤0.01% | 4776 |
|
|
2022
Q1 | $3.52M | Buy |
50,148
+7,079
| +16% | +$497K | ﹤0.01% | 2219 |
|
|
2021
Q4 | $4.15M | Sell |
43,069
-119
| -0.3% | -$11.5K | ﹤0.01% | 2262 |
|
|
2021
Q3 | $3.75M | Buy |
43,188
+27,762
| +180% | +$2.41M | ﹤0.01% | 2253 |
|
|
2021
Q2 | $1.26M | Buy |
15,426
+9,408
| +156% | +$770K | ﹤0.01% | 3073 |
|
|
2021
Q1 | $573K | Sell |
6,018
-2,351
| -28% | -$224K | ﹤0.01% | 3834 |
|
|
2020
Q4 | $519K | Buy |
8,369
+636
| +8% | +$39.4K | ﹤0.01% | 3657 |
|
|
2020
Q3 | $460K | Sell |
7,733
-4,416
| -36% | -$263K | ﹤0.01% | 3490 |
|
|
2020
Q2 | $848K | Buy |
12,149
+5,195
| +75% | +$363K | ﹤0.01% | 2950 |
|
|
2020
Q1 | $315K | Sell |
6,954
-13,949
| -67% | -$632K | ﹤0.01% | 3562 |
|
|
2019
Q4 | $1.36M | Sell |
20,903
-59,170
| -74% | -$3.85M | ﹤0.01% | 3084 |
|
|
2019
Q3 | $4.97M | Buy |
80,073
+62,127
| +346% | +$3.86M | ﹤0.01% | 1853 |
|
|
2019
Q2 | $1.28M | Sell |
17,946
-38,723
| -68% | -$2.76M | ﹤0.01% | 2862 |
|
|
2019
Q1 | $4.44M | Sell |
56,669
-17,723
| -24% | -$1.39M | ﹤0.01% | 1852 |
|
|
2018
Q4 | $6.3M | Buy |
74,392
+12,697
| +21% | +$1.07M | ﹤0.01% | 1540 |
|
|
2018
Q3 | $10.6M | Buy |
61,695
+30,295
| +96% | +$5.19M | ﹤0.01% | 1383 |
|
|
2018
Q2 | $4.06M | Sell |
31,400
-68,233
| -68% | -$8.82M | ﹤0.01% | 2024 |
|
|
2018
Q1 | $10.3M | Buy |
99,633
+82,019
| +466% | +$8.45M | ﹤0.01% | 1314 |
|
|
2017
Q4 | $1.51M | Sell |
17,614
-25,989
| -60% | -$2.22M | ﹤0.01% | 2731 |
|
|
2017
Q3 | $3.7M | Sell |
43,603
-18,977
| -30% | -$1.61M | ﹤0.01% | 1991 |
|
|
2017
Q2 | $4.74M | Buy |
62,580
+32,474
| +108% | +$2.46M | ﹤0.01% | 1731 |
|
|
2017
Q1 | $1.99M | Sell |
30,106
-60,502
| -67% | -$4M | ﹤0.01% | 2349 |
|
|
2016
Q4 | $5.74M | Buy |
90,608
+44,823
| +98% | +$2.84M | ﹤0.01% | 1495 |
|
|
2016
Q3 | $2.92M | Sell |
45,785
-29,040
| -39% | -$1.85M | ﹤0.01% | 1937 |
|
|
2016
Q2 | $5.57M | Buy |
74,825
+55,400
| +285% | +$4.12M | ﹤0.01% | 1426 |
|
|
2016
Q1 | $1.3M | Sell |
19,425
-87,755
| -82% | -$5.86M | ﹤0.01% | 2467 |
|
|
2015
Q4 | $7.25M | Buy |
107,180
+55,022
| +105% | +$3.72M | ﹤0.01% | 1277 |
|
|
2015
Q3 | $2.79M | Buy |
52,158
+12,001
| +30% | +$641K | ﹤0.01% | 1911 |
|
|
2015
Q2 | $2.53M | Buy |
40,157
+3,211
| +9% | +$202K | ﹤0.01% | 2122 |
|
|
2015
Q1 | $1.78M | Buy |
36,946
+23,460
| +174% | +$1.13M | ﹤0.01% | 2379 |
|
|
2014
Q4 | $448K | Buy |
+13,486
| New | +$448K | ﹤0.01% | 3275 |
|